Amerita, Inc.

Amerita, Inc.

Amerita, Inc.

Overview
Date Founded

2006

Headquarters

20 Fairbanks,Suite 175,Irvine, CA 92618

Type of Company

Private

Industries

Retail: Drug Stores
Hospitals & Patient Services

Company Description

Amerita, Inc. provides complex pharmaceutical products and clinical services to patients outside of the hospital. Its services include infusion services, injectable medications, enteral therapy and parenteral therapy, hospice medications and Synagis. The company was founded in 2006 by Jim Glynn and is headquartered in Irvine, CA.

Executives & Employees

President

Chief Financial Officer

Director-Controller

Director, Human Resources

Vice President, Operations

Vice President-Sales

Vice President, Operations

Vice President Revenue Cycle Management

Vice President, Operations

Account Executive

Board of Directors

President & Chief Executive Officer at Vision Source LP

Paths to Amerita, Inc.
Potential Connections via
Relationship Science
You
Amerita, Inc.
Recent Transactions
Details Hidden

Amerita, Inc., PharMerica Corp. purchase Coastal Pharmaceutical Services Corp.

Details Hidden

Amerita, Inc., PharMerica Corp. purchase Prescott IV Care, Inc.

Details Hidden

PharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Transaction Advisors
Investment Advisor

Advised onPharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Legal Advisor

Advised onPharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Legal Advisor

Advised onPharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Legal Advisor

Advised onPharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Investment Advisor

Advised onPharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Attorney

Advised onPharMerica Corp. purchases Amerita, Inc. from Ferrer Freeman & Co. LLC

Investors
Details Hidden

Ferrer Freeman & Co. (FFC) invests exclusively in growth-stage healthcare and healthcare-related companies, including healthcare services, clinical products and outsourcing/infrastructure. They invest from $15 million to $45 million in equity per company for growth capital, buildups and select buyouts. Growth capital is used to fund acquisitions, product commercialization, geographical expansion or facility expansion. FFC usually invests growth capital in private companies, but will occasionally provide growth capital to public companies as well. Buildup capital supports a business plan which does not usually have an existing operating business. FFC and management usually agree on a plan that requires the measured use of capital over time to build new operations, acquire smaller companies or some combination of both. The firm participates in buyout transactions when they believe they have unique insight into the target company or its management team.FFC invests in the appropriate security to match the risk of the investment, the future capital needs of the business and the requirements of management and existing investors. This includes equity and quasi-equity securities such as common stock, convertible preferred stock and convertible subordinated debt. FCC usually serves as the sole institutional investor or as part of an investment group. They typically take at least one seat on their portfolio companies' board of directors and take an active role in board activities.